Carl June lends 'wings' to Chinese CAR-T startup led by former postdoc, pursuing off-the-shelf approach with CRISPR flavor
Carl June still has plenty of energy to bring forth new iterations of CAR-T technology — wherever they’re coming from.
Adding another role to his already lengthy list of titles, June is joining the scientific advisory board at Nanjing Bioheng Biotech, where he will serve as chairman.
The appointment, if slightly out of the ordinary, is both a testament to the fruitfulness of June’s lab at the University of Pennsylvania and China’s increasing appeal to biotech entrepreneurs educated overseas.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.